The Federal Ministry of Education and Research (BMBF) supports and coordinates strategic research and innovation partnerships initiated and coordinated by universities of applied sciences with the theme-oriented funding measure "Strong universities of applied sciences - impulse for the region" (FH-Impuls).
In January 2018, a new paper was published as part of the impulse project M²OGA:
The Innovation Partnership M²Aind - Multimodal Analytics and Intelligent Sensorics for the Healthcare Industry is a network involving Mannheim University of Applied Sciences and numerous companies in the healthcare industry and creates practice-relevant solutions for industry in the Rhine-Neckar Metropolitan Region.
Read more here.
Innovation Partnership M²Aind looks back on a successful international congress in the field of mass spectrometry with Bruker Daltonik GmbH
In cooperation with Bruker Daltonik GmbH, the innovation partnership M²Aind from 21.-22. February 2018, the congress "MALDI Innovations in Pharma 2018" at the University of Mannheim. Over a period of two days, around 120 industry and academia representatives from the pharmaceutical, chemical and biotechnology sectors took the opportunity to network and share the latest research findings. The focus of the event was, on the one hand, mark-free high-throughput screening methods using matrix-assisted laser desorption / ionization (MALDI) mass spectrometry as well as applications of MALDI-MS imaging in the pharmaceutical industry and chemical biology. There was a great deal of interest among the audience in the various areas of application presented by the speakers in 16 lectures.
Read on here.
17.7.2018 - 4pm to 7pm
3. M²Aind Talk
Your get-together of the health industry for the metropolitan area of Rhein-Main-Neckar
Take the opportunity to share food and drink with representatives of the regional health industry and learn about the latest industry news!
In line with our momentum project M²OGA, three lectures on "3D cell culture - technology and application" are held by 300 Microns GmbH, Merck KGaA and BRAIN AG.
Further information about lectures and venue can be found here.